DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 25 filers reported holding DIAMEDICA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $421 | -16.0% | 163 | +40.5% | 0.00% | – |
| Q2 2023 | $501 | +193.0% | 116 | +3.6% | 0.00% | – |
| Q1 2023 | $171 | -1.7% | 112 | +1.8% | 0.00% | – |
| Q4 2022 | $174 | – | 110 | +2.8% | 0.00% | – |
| Q3 2022 | $0 | – | 107 | -39.5% | 0.00% | – |
| Q2 2022 | $0 | – | 177 | +8.6% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 163 | +0.6% | 0.00% | – |
| Q4 2021 | $1,000 | – | 162 | +40.9% | 0.00% | – |
| Q3 2021 | $0 | – | 115 | +9.5% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 105 | -0.9% | 0.00% | – |
| Q1 2021 | $1,000 | -95.2% | 106 | -95.0% | 0.00% | – |
| Q4 2020 | $21,000 | +162.5% | 2,106 | +1.5% | 0.00% | – |
| Q3 2020 | $8,000 | -42.9% | 2,075 | +0.4% | 0.00% | – |
| Q2 2020 | $14,000 | – | 2,067 | +2985.1% | 0.00% | – |
| Q1 2020 | $0 | – | 67 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,197,245 | $2,993,000 | 1.24% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 265,000 | $663,000 | 0.40% |
| COOPERMAN LEON G | 812,508 | $2,031,270 | 0.11% |
| Ikarian Capital, LLC | 221,252 | $553,000 | 0.07% |
| Shay Capital LLC | 10,000 | $25,000 | 0.00% |
| Sandy Cove Advisors, LLC | 1,200 | $3,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 20,603 | $52,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 1,269 | $3,000 | 0.00% |
| Patriot Financial Group Insurance Agency, LLC | 1,300 | $3,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 20 | $0 | 0.00% |